Cineworld shares: bull vs bear

We believe that considering a diverse range of insights makes us better investors. Here, two contributors debate Cineworld shares.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Bullish: Manika Premsingh

Multinational cinema operator Cineworld (LSE: CINE) went through a rough time in the pandemic. And unlike many other pandemic-impacted stocks, its share price has still not returned to pre-pandemic levels. It is highly sensitive to any Covid-19 related developments, which could potentially bring its business to a grinding halt in a flash, like it did last year.

Yet, I have been bullish on the stock for a while now and have even bought it. The reason is not hard to guess. It is one of my recovery picks, because I think that cinemas could boom as the pandemic recedes and the recovery takes hold.

Already, there are signs of improvement in Cineworld’s performance. As per its latest trading update, the company’s revenues in October were back to 90% of their pre-pandemic levels of 2019. The numbers for the UK and Ireland are particularly encouraging, since they have actually surpassed the 2019 revenues.

The rest of 2021 also looks good for it, with blockbusters like Spider-Man: No Way Home, The Matrix Resurrections and Sing 2 slated for release. 2022 is expected to be dotted with big releases as well, including those that were delayed because of Covid-19. So there is little reason to doubt, in my view, that the FTSE 250 stock could be in much better shape by this time next year.

There could be stumbling blocks along the way ,of course. It has a mountain of debt to pay off, the pandemic is still something of a challenge, and rising inflation could slow down recovery significantly, which could impact investor sentiment. On the whole, though, I am optimistic for Cineworld.

Manika Premsingh owns shares of Cineworld


Bearish: Paul Summers

I’ve been bearish on Cineworld shares for as long as I can remember. Based on the sheer number of headwinds faced by the company, I can’t see this changing any time soon.

This stance might seem odd considering the success of No Time to Die and the encouraging slate of films due for release in 2022 (including Matrix 4, Top Gun 2 and Jurassic World: Dominion). But let’s be realistic. Like the stock market, nothing is guaranteed in the movie world. Nailed-on blockbusters can be poorly received. Even better-than-expected weather can impact Cineworld’s earnings. This makes the industry pretty risky for investors, in my opinion.

In addition to this, you have the seemingly perpetual rise of streaming services such as Netflix and Amazon Prime. The shorter window of opportunity Cineworld now has between a film being shown on the silver screen and being available to watch from the comfort of my own home is worrying.

By far Cineworld’s biggest problem, however, is that massive debt pile. Even if the pandemic is nearing its final chapter, that burden will still take a long time to shift. This may be the reason why the company is easily the most shorted stock on the UK market.

The cinema operator might have the potential to make money for traders nipping in and out of positions. For a long-term investor like me, however, Cineworld simply doesn’t make the grade. 

Paul Summers has no position in any of the shares mentioned.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool UK has recommended Amazon. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »